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Abstract 29 
 30 
 Schistosoma bovis is a parasite of wild and domestic ruminants that is broadly 31 
distributed throughout many tropical and temperate regions of the old world. S. bovis causes 32 
severe health problems and significant economic losses in livestock, but in contrast to human 33 
schistosomes, S. bovis has been little investigated at a molecular level. Since schistosome 34 
glycans and glycoproteins can play important roles in the host-parasite interplay, the aims of the 35 
present work were: (i) to characterize the glycans expressed by adult S. bovis worms on their 36 
excreted/secreted (ES) and tegumental (TG) glycoproteins, and (ii) to identify their carrier 37 
protein backbones by mass spectrometry. Using a panel of lectins and monoclonal and 38 
polyclonal anti-glycan antibodies we observed: (i) the absence of sialic acid in S. bovis; (ii) the 39 
presence of complex-type N-glycans and LDN antennae on ES glycoproteins; (iii) the presence 40 
of glycans containing the Fucα1-2Galβ motif in many TG glycoproteins, and (iv) the presence 41 
of glycans containing the Fucα1-3GlcNAc motif on many ES and TG glycoproteins but, 42 
simultaneously, the absence of the F-LDN(-F) glycans from both the ES and TG glycoproteins. 43 
Interestingly, we also found the LewisX and LewisY antigens co-expressed on several TG 44 
isoforms of ATP:guanidino kinase and glyceraldehyde-3-phosphate dehydrogenase. Finally, by 45 
ELISA we observed the presence of antibodies against LewisX, LewisY and F-LDN(-F) in the 46 
sera of sheep experimentally infected with S. bovis. 47 
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1. Introduction 50 
 51 
Blood flukes of the genus Schistosoma are one of the major causes of human and 52 
domestic animal disease in many tropical and subtropical countries. There are three major 53 
species that infect humans, namely S. mansoni, S. japonicum and S. haematobium, and at least 54 
ten species have been reported to infect domestic ruminants naturally. Among these second 55 
species, only S. mattheei and S. bovis have received some attention, mainly because of their 56 
recognized veterinary significance (De Bont and Vercruysse, 1998; Vercruysse and Gabriel, 57 
2005). 58 
S. bovis lives in the portal mesenteric system of its ruminant hosts and shows a wide 59 
geographic distribution that includes practically the whole of Africa, the Middle East (Israel, 60 
Iran, Iraq), and the Mediterranean region (Corsica, Sardinia, Sicily, Italy and Spain) (De Bont 61 
and Vercruysse, 1998; Moné et al., 1999). In addition, S. bovis belongs to the same species 62 
complex as the human pathogen S. haematobium and indeed is an immunological analogue of S. 63 
haematobium (Agnew et al., 1989), making studies on S. bovis an attractive goal from the 64 
perspectives of both veterinary and comparative medicine. 65 
Nonetheless, in spite of the veterinary importance of this parasite, studies on S. bovis 66 
have been scant in comparison with as those carried out on human schistosomes and have 67 
mainly focused on the life cycle and epidemiology of the worm. The pathology and treatment of 68 
the infection and certain features of the host immune response have also been studied, but little 69 
is known of the immunological mechanisms involved in ruminant schistosomiasis (Johansen et 70 
al., 1996; De Bont and Vercruysse, 1998; Viana da Costa et al., 1998; Rodriguez-Osorio et al., 71 
1999; Vercruysse and Gabriel, 2005). Similarly, work aimed at the molecular characterization 72 
of S. bovis has been scarce and has focused on only a few molecules, such as glutathione S-73 
transferase, which has been addressed in several studies owing to its potential as a vaccine 74 
(Trottein et al., 1992; Boulanger et al., 1999; De Bont et al., 2003). 75 
The need for a better understanding on how S. bovis interacts with its host at molecular 76 
level, as well as the search for diagnostic antigens and targets for new vaccines and drugs 77 
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encouraged us to study the parasite molecules involved in the host-parasite interplay. Since such 78 
molecules should be among those that the parasite exposes to the host along the period of 79 
infection, we began our study by carrying out a proteomic analysis of the tegument and the 80 
excreted/secreted products of the adult worms (Pérez-Sánchez et al., 2006). This study allowed 81 
us to identify 18 parasite proteins located at the host-parasite interface. At least 4 of these 82 
proteins (enolase, glyceraldehyde-3-phosphate dehydrogenase, serine protease inhibitor and 83 
superoxide dismutase) could counteract the host defence mechanisms. The remaining proteins 84 
identified are also likely to play some kind of role in the host-S. bovis relationships not only 85 
because they form part of the host-parasite interface but also because, for many of them, their 86 
molecular functions suggest that this would indeed be the case. 87 
While very important, proteins are not the only kind of parasite molecules involved in 88 
the schistosome-host interactions. It is currently recognized that schistosomes produce a variety 89 
of complex glycans, which are expressed on glycolipids and glycoproteins, and that these 90 
glycans can play important roles in the induction and modulation of the host immune response 91 
as well as in the immunopathology of schistosomiasis (Hokke and Deelder, 2001; Nyame et al. 92 
2003, 2004; Hokke and Yazdanbakhsh, 2005). For this reason, schistosome glycans and 93 
glycoconjugates are now regarded as good immunodiagnostic targets and potential targets for 94 
vaccine development (Nyame et al., 2003, 2004). In fact, schistosome glycobiology has recently 95 
become an area of intensive research and a significant amount of structural and functional 96 
information on schistosome glycans is available, at least for human schistosomes. What is still 97 
almost completely lacking, however, is information about which glycoproteins these glycans are 98 
expressed on (Hokke and Yazdanbakshs, 2005). 99 
Regarding S. bovis, almost nothing is known about its glycans and the glycoproteins on 100 
which are they expressed. It is necessary to determine which proteins of S. bovis are 101 
glycoproteins and how these glycoproteins are glycosylated. In this work, we initiated such a 102 
determination by studying the glycans expressed on the excreted/secreted and tegumental 103 
glycoproteins of adult S. bovis worms. Since these two glycoprotein fractions are exposed to the 104 
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host during infection, it is likely that their glycans would be involved in the host-parasite 105 
interplay as immunogens or immunomodulators. 106 
We paid particular attention to some of the carbohydrate motifs that are known to occur 107 
in human schistosomes and that have immunogenic and immunomodulatory properties, such as 108 
GalNAcβ1-4GlcNAcβ1 (LDN), GalNAcβ1-4(Fucα1-3)GlcNAcβ1 (LDN-F), Fucα1-109 
3GalNAcβ1-4GlcNAcβ1 (F-LDN), Fucα1-3GalNAcβ1-4(Fucα1-3)GlcNAcβ1 (F-LDN-F) and 110 
Galβ1-4(Fucα1-3)GlcNAcβ1 (LewisX, LeX) (Van Liempt et al., 2004; Hokke and 111 
Yazdanbakshs, 2005; Meyer et al., 2005; Robijn et al., 2005; van de Vijver et al., 2006; Wuhrer 112 
et al., 2006a, 2006b). Additionally, although the tetrasaccharide Fucα1-2Galβ1-4(Fucα1-113 
3)GlcNAcβ1 (LewisY, LeY) has so far not been found in human schistosomes (Nyame  et al., 114 
1998), here we also investigated the presence of LeY on the glycoproteins of adult S. bovis 115 
worms. 116 
With these aims, two extracts containing the tegumental and excreted/secreted proteins 117 
of S. bovis adult worms were probed with eight lectins, two monoclonal antibodies (anti-LeX 118 
and anti-LeY), and a polyclonal antibody against Keyhole limpet haemocyanin (KLH). KLH and 119 
human schistosomes share the carbohydrate epitopes F-LDN and F-LDN-F (Geyer et al., 2005; 120 
Robijn et al., 2005), allowing the anti-KLH antibody to recognize those epitopes, if present, in 121 
S. bovis. Both protein extracts were analysed by combining lectin blotting, Western blotting and 122 
immunoprecipitation with 1-D and 2-D electrophoresis. The glycoproteins thus detected were 123 
identified by mass spectrometry analysis and, finally, by ELISA the presence of antibodies 124 
against LeX, LeY and F-LDN(-F) in the sera of sheep experimentally infected with S. bovis was 125 
demonstrated. 126 
 127 
2. Material and Methods. 128 
 129 
2.2. Maintenance of Schistosoma bovis life-cycle 130 
 131 
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A strain of S. bovis from Salamanca (Spain) was maintained at the laboratory in its 132 
natural hosts: Planorbarius metidjensis snails and sheep. Each snail was infected with five 133 
miracidia from eggs obtained from the faeces of experimentally infected sheep. The infected 134 
snails were maintained at the laboratory under controlled conditions until the emission of 135 
cercariae. Then, the sheep were infected percutaneously with 2,000 S. bovis cercariae by 136 
submerging a fore-limb for 30 min in 150 ml of cercarial suspension. At 6 months post-137 
infection the sheep were sedated with ketamine (10 mg/kg) and then sacrificed by bleeding after 138 
sectioning the jugular vein. S. bovis adult worms were recovered by dissection of mesenteric 139 
vessels from the entire gut and washed thoroughly in PBS at 37ºC. The viability of the worms 140 
was examined microscopically, after which intact parasites were processed immediately to 141 
obtain the two protein extracts to be studied (see below). The sheep were bled before and along 142 
the infection to obtain sera. As a rule, bleeding was performed once a week during the first four 143 
weeks post-infection and then once a month until the time of sacrifice. 144 
 145 
2.2. Preparation of extracts of excretory-secretory and tegumental proteins 146 
 147 
Extracts of excretory-secretory and tegumental proteins were prepared from live adult 148 
worms as follows. The parasites were washed twice in RPMI 1640 medium supplemented with 149 
penicillin (100 U/ml) and streptomycin (100 µg/ml) and then cultured for 6 h in the same 150 
medium at 37ºC and 5% CO2. This culture medium was recovered and designated ES. 151 
Following this, to obtain the tegumental extract the parasites were washed twice in TBS and 152 
incubated in 1% Triton X-100 in TBS at 4ºC with gentle shaking for 30 min, after which the 153 
medium from this incubation, designated TG, was recovered. Both extracts -ES and TG- were 154 
clarified by centrifugation at 10,000 g, dialyzed against water for 24 h, and concentrated by 155 
vacuum centrifugation to a concentration of > 3 µg/µl. A cocktail of protease inhibitors (1mM 156 
EDTA, 1mM N-Ethylmaleimide, 0.1 µM Pepstatin A, 1 mM PMSF and 0.1 mM N-Tosylamide-157 
L-phenylalanine chloromethyl ketone) was added to each extract (Maizels et al., 1991). The 158 
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protein concentration of the ES extract was measured with the Bradford assay (Bio-Rad, 159 
Hercules, CA, USA) and that of the TG by the method of Markwell et al. (1978). 160 
 161 
2.3. SDS-PAGE 162 
 163 
Protein samples were subjected to SDS-PAGE in a Laemmli (1970) discontinuous gel 164 
system using the Mini-Protean Cell system (Bio-Rad). The stacking gel was 3% and the 165 
resolving gel was a 5-20% gradient. Usually, the gels were loaded with 10 µg of protein per 166 
lane. After running, the gels were either electrotransferred onto nitrocellulose membranes or 167 
stained with silver nitrate. The electrotransfer step was carried out in 2 mM Tris, 192 mM 168 
glycine buffer, pH 8, at 400 mA for 90 min. 169 
 170 
2.4. Two-dimensional electrophoresis (2-DE) 171 
 172 
2-DE was performed as described in Perez-Sánchez et al. (2006). The isoelectric 173 
focusing (IEF) was run in 7-cm IPG strips (Bio-Rad) with linear pH ranges of 5-8 and 7-10 174 
using a Protean IEF Cell (Bio-Rad). Protein samples (25 µg of ES or TG, as well as 175 
immunoprecipitation pellets -see below-) were diluted in 125 µl of rehydration buffer (7 M urea, 176 
2 M thiourea, 4% CHAPS, 50 mM DTT, 0.2% IPG buffer, bromophenol blue traces) and were 177 
allowed to mix gently for 1 h at room temperature before centrifugation at 18,000 g over 30 min 178 
to remove all particulate material. The supernatants were applied to the IPG strips by in-gel 179 
rehydration at 20ºC for at least 12 h. IEF was run at 50 µA/strip for a total of 20,000 Vh. Next, 180 
the strips were reduced in equilibration buffer (6 M urea, 0.05 M Tris pH 8.8, 2% SDS, 20% 181 
glycerol) containing 2% DTT over 15 min and then alkylated in equilibration buffer containing 182 
2.5% iodoacetamide for 10 min. The second dimension was performed on 12% polyacrylamide 183 
gels and the resulting 2-D gels were either stained with a mass spectrometry-compatible silver 184 
stain (Stochaj et al., 2003), or electrotransferred onto nitrocellulose membranes in a similar way 185 
to that of  the 1-D gels. The stained 2-D gels were scanned using an ImageScanner (Amersham 186 
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Biosciences, Uppsala, Sweden) and their images were analysed using the ImageMaster 2D 187 
Platinum Software v5.0 (Amersham Biosciences). 188 
 189 
2.5. 1-D and 2-D lectin blotting 190 
 191 
Samples of ES and TG extracts, previously resolved by SDS-PAGE and 192 
electrotransferred to nitrocellulose membranes, were probed with the eight lectins listed in 193 
Table 1. The digoxigenin-labelled lectins GNA, SNA, MAA, DSA and PNA, all of them 194 
included in the DIG Glycan Differentiation Kit (Roche, Mannheim, Germany), were used 195 
following the instructions of the kit manufacturer. Briefly, the nitrocellulose membranes were 196 
blocked and subsequently incubated with the corresponding lectin (see Table 1 for lectin 197 
concentration). Then, they were incubated with an alkaline phosphatase-conjugated anti-198 
digoxigenin antibody (1:1000) and the reactive bands were revealed with a substrate solution 199 
containing NBT and X-phosphate. 200 
The biotinylated lectins WFA, LTA and UEA-I (Vector Laboratories, Peterborough, 201 
UK) were used as follows. Nitrocellulose membranes were blocked with 3% BSA in TBS (50 202 
mM Tris-HCl, 150 mM NaCl, pH 7.5), washed 3 times with TBS containing 0.3% Tween-20, 203 
and incubated with the respective lectin diluted in dilution buffer (TBS, 0.05% Tween-20, 1% 204 
BSA). After 3 new washes, the membranes were incubated with 1:1000 avidin-peroxidase 205 
(Sigma, Saint Louis, MO, USA) in dilution buffer and washed again 3 times. Reactive bands 206 
were revealed with 4-Cl-1-naphthol. Incubations were carried out at room temperature for 1 h, 207 
and the washes were done for 10 min per each wash. 208 
The lectins GNA, WFA, LTA and UEA-I were those that recognized bands on one or 209 
both extracts. Consequently, a second 1-D blotting with these lectins was performed, but this 210 
time including the appropriate monosaccharide as a lectin binding inhibitor; respectively, α-211 
methyl-D-mannoside (0.5 M), N-acetyl-D-galactosamine (0.2 M) and L-fucose (1 and 3 M). All 212 
three monosaccharides were purchased from Sigma. 213 
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After the inhibition experiments had been completed, these four lectins were used again 214 
as probes in a subsequent 2-D lectin blotting. The ES extract was resolved in 2-D gels in the 5-8 215 
and 7-10 pH ranges, transferred to nitrocellulose membranes, and re-screened with GNA, WFA 216 
and LTA. The TG extract was re-screened in a similar way, but in this case with LTA and UEA-217 
I. Blotting conditions were similar to that used in the 1-D lectin analysis. The resulting 2-D 218 
blots were scanned and their images were analysed using the ImageMaster software. These blots 219 
and their homologous silver-stained gels were aligned to isoelectric point (pI) and molecular 220 
weight (MW) and then matched by ImageMaster software in order to identify the lectin-binding 221 
spots in the gels. Then, the spots of interest were excised from the gels and analysed by mass 222 
spectrometry for protein identification. 223 
  224 
2.6. 1-D Western blotting 225 
 226 
ES and TG samples were resolved by SDS-PAGE and transferred to nitrocellulose 227 
membranes. The membranes were blocked with 2% BSA in PBS and washed 3 times with PBS 228 
containing 0.05% Tween 20. Following this, they were incubated with 2 µg/ml of primary 229 
antibody in dilution buffer (PBS, 0.05% Tween 20, 1% BSA): anti-LeX and anti-LeY 230 
monoclonal antibodies (Calbiochem, San Diego, CA, USA) and rabbit anti-KLH policlonal 231 
antibody (Sigma). After 3 new washes, the membranes were incubated with the respective 232 
secondary antibody: peroxidase-conjugated goat anti-mouse IgM (1:1000) (Stressgen 233 
Bioreagents, Victoria, Canada) and peroxidase-labelled goat anti-rabbit IgG (1:5000) (Sigma). 234 
The membranes were washed again and the reactive bands were visualised with either 4-Cl-1-235 
naphthol or with the Immun-Star HRP chemiluminescent substrate (Bio-Rad) followed by 236 
digitalization using the Fluor-S Multimager system (Bio-Rad). Incubations were performed at 237 
37 ºC for 1 h, and the washes were carried out at room temperature for 10 min per each wash. 238 
 239 
2.7. Immunoprecipitation (IP) 240 
 241 
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The glycoproteins of the TG extract that were recognized in the Western blots by the 242 
monoclonal antibodies anti-LeX and anti-LeY were subsequently separated by IP. The IP 243 
protocol was an adaptation of that described by Harlow and Lane (1988) and proceeded as 244 
follows. 245 
Samples of 100 µg of protein G-Sepharose 4B (Sigma) were sensitised with 10 µg of 246 
each monoclonal antibody in 100 µl of PBS. The reactions were carried out in 1.5 ml test tubes 247 
at 4ºC for 12-16 h with gentle shaking. They were then centrifuged for 2 min at 3000 rpm and 248 
the supernatants were removed (non-bound material). The pellets (bound antibody) were 249 
washed 3 times with 1 ml of PBS and resuspended in 100 µl of PBS. The binding of the 250 
antibodies to protein G was checked by running 10 µl of each supernatant and pellet in SDS-251 
PAGE. In parallel, to discard direct binding of TG components to protein G, 100 µg of TG were 252 
incubated with 100 µg of protein G-Sepharose 4B. 253 
Both monoclonal-sensitised protein G-Sepharose pellets (containing close to 9 µg of 254 
bound antibody each) were then incubated with 100 µg of TG in a total volume of 100 µl of 255 
PBS at 37 ºC for 1 h with gentle shaking. Following this, they were centrifuged as above and the 256 
supernatants were removed and preserved. The pellets were washed and resuspended in 100 µl 257 
of PBS. The IP results were checked by running 20 µl aliquots of both supernatants and pellets 258 
in SDS-PAGE. The remaining 80 µl of each pellet was then electrophoresed in 2-D gels in the 259 
5-8 and 7-10 pH ranges. The gels were stained with a mass spectrometry-compatible silver 260 
stain, and the major spots corresponding to the immunocaptured proteins were excised from the 261 
gels and analysed by mass spectrometry. 262 
 263 
2.8. Mass spectrometry analysis and protein identification 264 
 265 
These analyses were carried out as described in Pérez-Sánchez et al. (2006). Protein 266 
spots were excised manually and then digested automatically using a Proteineer DP protein 267 
digestion station (Bruker-Daltonics). The digestion protocol used was that of Schevchenko et al. 268 
(1996). For peptide mass fingerprinting and the acquisition of LIFT TOF/TOF spectra, an 269 
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aliquot of α-cyano-4-hydroxycinnamic acid in 33% aqueous acetonitrile and 0.1% 270 
trifluoroacetic acid was mixed with an aliquot of the above digestion solution and the mixture 271 
was deposited onto an AnchorChip MALDI probe (Bruker-Daltonics). 272 
Peptide mass fingerprint spectra were measured on a Bruker Ultraflex TOF/TOF 273 
MALDI mass spectrometer (Bruker-Daltonics) (Suckau et al., 2003) in positive ion reflector 274 
mode. Mass measurements were performed automatically using fuzzy logic-based software or 275 
manually. Each spectrum was calibrated internally with the mass signals of trypsin autolysis 276 
ions to reach a typical mass measurement accuracy of ± 25 ppm. The measured tryptic peptide 277 
masses were transferred by means of the MS BioTools program (Bruker-Daltonics) as inputs to 278 
search the NCBInr database using Mascot software (Matrix Science; London, UK). When 279 
necessary, MS/MS data from LIFT TOF/TOF spectra were combined with PMF data for 280 
database searches with a parent ion mass tolerance of 20 – 40 ppm and a fragment ion mass 281 
accuracy of 0.25 – 0.50 Da. 282 
 283 
2.9. ELISA 284 
 285 
 ELISA was performed to investigate the presence of antibodies against LeX, LeY and F-286 
LDN(-F) in the sera of sheep experimentally infected with S. bovis. To do so, the sera of 3 sheep 287 
were analysed by ELISA against the following antigens: ES and TG extracts, KLH (Sigma) and 288 
the neoglycoproteins LNFPIII-BSA (Dextra Laboratories, Reading, UK) and LeY 289 
hexasaccharide-BSA (LeY-BSA). LeY-BSA was synthesized by the reductive amidation method 290 
of Gray (1974), following a procedure similar to that described by Nyame et al. (1996). Briefly, 291 
200 µg of LeY-hexasaccharide (Dextra Laboratories) was mixed with 67 µg of BSA and 52 µg 292 
of NaBH3CN in 50 µl 0.2 mM KH2PO4 pH 7.0 and left at room temperature for 14 days to allow 293 
covalent binding of the sugar to BSA. The neoglycoprotein synthesized was purified from 294 
uncoupled sugar and salts by dialysis using Slide-A-Lyzer Mini Dialysis Units (Pierce 295 
Biotechnology, Rockford, IL, USA). Analysis by Western blot with the anti-LeY monoclonal 296 
antibody revealed that the oligosaccharide was coupled to BSA. 297 
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 ELISA plates were coated overnight at room temperature with 0.2 µg of antigen/well in 298 
100 µl of carbonate buffer, pH 9.6, and subsequently blocked with 5% BSA in PBS at 37ºC for 299 
2 h. The wells were washed 4 times with PBS containing 0.05% Tween 20 and incubated at 37 300 
ºC for 1 h with 100 µl of the sera diluted 1:50 in dilution buffer (PBS, 0.3% Tween 20, 1% 301 
BSA). After 4 new washes, the wells were incubated at 37 ºC for 1 h with 100 µl of peroxidase-302 
labelled donkey anti-sheep IgG (1:8000) (Sigma) or peroxidase-labelled rabbit anti-sheep IgM 303 
(1:6000) (Bethyl Laboratories, Montgomery, TX, USA) and washed again 4 times. Finally, 304 
ortho-phenylene-diamine was used as chromogen substrate for peroxidase. 305 
 306 
3. Results 307 
 308 
3.1. 1-D lectin blots of ES and TG extracts 309 
 310 
 As can be seen in Fig. 1(A), both extracts were resolved by SDS-PAGE in 311 
approximately 30 bands, whose MWs ranged between 7 and 200 kDa. Fig. 1(C) shows that 312 
lectins SNA, MAA, DSA and PNA did not recognize any band on any extract apart from some 313 
unspecific binding of lectin MAA on TG. This lack of reactivity indicates that the ES and TG 314 
glycoproteins do not contain sialic acid (NeuNAc), lactosamine (LacNAc) and Galβ1-3GalNAc. 315 
Lectins GNA and WFA recognized a group of bands of high MW on the ES -although 316 
not on the TG-, which is indicative of the presence, respectively, of terminal mannosyl residues 317 
and GalNAcβ1-4GlcNAcβ1 (LDN) on the ES glycoproteins. By contrast, lectin UEA-I 318 
recognized numerous bands on the TG -but not on the ES-, signalling the presence of the Fucα1-319 
2Galβ terminal sequence on numerous TG glycoproteins. Finally, lectin LTA recognized 320 
numerous bands on both the ES and TG, showing that the Fucα1-3GlcNAc motif is abundantly 321 
expressed on the glycoproteins of both extracts. The binding of GNA, WFA, LTA and UEA-I to 322 
those glycoproteins was inhibited by the corresponding mononosaccharide, except in the case of 323 
a broad band of 55 kDa revealed by GNA on TG, which did not disappear in the inhibition 324 
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experiment (not shown); furthermore, no reactive bands were observed when the ES and TG 325 
were probed directly with avidin-peroxidase alone. 326 
 327 
3.2. 2-D lectin blots and identification of lectin-binding proteins of the ES and TG extracts 328 
 329 
 Both extracts were re-screened by 2-D lectin blotting but using only the lectins that gave 330 
positive reactions in the 1-D blotting, i.e., GNA, WFA, LTA and UEA-I. 331 
 The ES extract resolved into approximately 400 spots, whose pIs and MWs ranged 332 
between pH 5-9 and 15-190 kDa (Fig. 2(A), 2(B)). LTA bound to 176 of these spots, which 333 
were distributed between pH 5-9 and 32-190 kDa (Fig. 2(C), 2(D)). By contrast, GNA (Fig. 334 
2(E), 2(F)) and WFA (Fig. 2(G), 2(H)) bound to only 20-25 spots, most of which were located 335 
between pH 5-5.7 and 46-190 kDa. Matching of the lectin blots with their homologous silver-336 
stained gels allowed us to localize in the 2-D gels a total of 55 of those spots recognized by the 337 
lectins (Fig. 2). These 55 spots were cut from the gels and subjected to MS analysis. Table 2 338 
shows the MS analysis results. Thirty-four spots out of 55 were identified and these 34 spots 339 
corresponded to 8 different glycoproteins, one from the host (pre-pro serum albumin) and 7 340 
from the parasite: surface protein-fluke (SPF), ATP:guanidino kinase (ATPGK), serine protease 341 
inhibitor (serpin), enolase, fructose 1,6 bisphosphate aldolase (FbisPA), glyceraldehyde-3-342 
phophate dehydrogenase (GAPDH) and cathepsin B endopeptidase (CBendo). For each protein 343 
we identified between 2 and 9 isoforms. Lectin LTA bound to all these ES glycoproteins except 344 
serpin and low MW SPF isoforms. On the other hand, lectin GNA bound to serpin and all SPF 345 
isoforms and lectin WFA bound to serpin and high MW SPF isoforms. 346 
 The TG extract resolved in more than 600 spots, whose pIs and MWs ranged between 347 
pH 5-9.5 and 15-160 kDa (Fig. 3(A), 3(B)). LTA bound to approximately 167 of these spots, 348 
which were distributed between pH 5.9-9.5 and 44-98 kDa (Fig 3(C), 3(D)). Lectin UEA-I 349 
bound to almost the same spots as LTA (Fig 3(E), 3(F)). Matching of the LTA and UEA-I blots 350 
with the homologous silver-stained gels allowed us to localize 38 lectin-binding spots in the 2-D 351 
gels (Fig. 3). These spots were cut from the gels and subjected to mass spectrometry analysis. 352 
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As can be seen in Table 3, 20 spots out of 38 were identified that corresponded to 5 different 353 
parasite glycoproteins: ATPGK, enolase, actin, FbisPA and GAPDH. For each glycoprotein we 354 
identified between 2 and 7 isoforms. All these isoforms, except those of actin, which only fixed 355 
LTA, were bound by both lectins: LTA and UEA-I.  356 
 Overall, we identified 8 parasite glycoproteins: 4 of them (ATPGK, enolase, FbisPA 357 
and GAPDH) were found in both extracts; another 3 (SPF, serpin and CBendo) were found only 358 
in the ES extract, and the remaining one, actin, was found only in the TG extract. All these 359 
glycoproteins except serpin fixed LTA, which indicates that they all carry the Fucα1-3GlcNAc 360 
motif. In contrast, only serpin and the high MW isoforms of SFP fixed GNA and WFA, 361 
indicating that these proteins are the ones that carry glycans containing terminal mannosyl 362 
residues and LDN. Finally, only the TG isoforms of ATPGK, enolase, FbisPA and GAPDH 363 
fixed UEA-I, showing that only these isoforms contain the Fucα1-2Galβ terminal sequence on 364 
their glycans. 365 
 366 
3.3. Western blots on ES and TG extracts with anti-KLH, anti-LeX and anti-LeY. 367 
 368 
 Fig. 1(B) shows that the anti-KLH antibody did not recognize any band on the ES or 369 
TG, which indicates that the F-LDN(-F) epitopes are not expressed on ES and TG glycoproteins 370 
of adult worms. 371 
On the other hand, the anti-LeX and anti-LeY monoclonal antibodies did not recognize 372 
any band on the ES extract, but they both recognized bands on the TG extract and, in fact, they 373 
recognized essentially the same ones: a band of 44 kDa and, less intensely, a band of nearly 92 374 
kDa (Fig. 1(B)). 375 
 376 
3.4. Immunoprecipitation and identification of the LeX- and LeY-bearing glycoproteins from the 377 
TG 378 
 379 
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 Fig. 4(A) shows that both monoclonal antibodies were efficiently coupled to protein G-380 
Sepharose 4B, and that no protein of TG bound directly to protein G-Sepharose 4B. 381 
Consequently, we incubated the TG with the anti-LeX and anti-LeY antibodies coupled to protein 382 
G-Sepharose 4B and examined the results of the immunoprecipitation by SDS-PAGE. Fig. 4(B) 383 
shows that both antibodies captured the two bands of 44 and 92 kDa previously revealed by 384 
Western blotting. Then, both IP pellets were subjected to 2-D electrophoresis and in both cases 385 
we observed the same result (Fig. 4(C)). Both bands of 92 kDa separated into 3 tiny spots each 386 
(spots no. 1-3 and 9-11) and both bands of 44 kDa separated into 5 spots each (spots no. 4-8 and 387 
12-16). All these spots were cut from the gels and identified by MS analysis. Table 4 shows that 388 
spots no. 1-3 and 9-11 were identified as ATPGK and that spots 4-8 and 12-16 were identified 389 
as GAPDH. 390 
 391 
3.5. Presence of antibodies against LeX, LeY and F-LDN(-F) in the sera of S. bovis-infected 392 
sheep. 393 
 394 
 The 3 S. bovis-infected sheep analysed developed very similar antibody responses. They 395 
all showed high levels of IgG and IgM anti-ES (Fig. 5(A), 5(B)) and moderate levels of IgG and 396 
IgM anti-TG (Fig. 5(C), 5(D)). The IgG anti-ES had reached maximum levels by the 8th week 397 
post-infection (w.p.i.) whereas the IgM anti-ES reached maximum levels early on, by the 4th 398 
w.p.i.; after that, the levels of both isotypes remained relatively constant until the sacrifice of 399 
sheep, in the 24th w.p.i. By contrast, the levels of both IgG and IgM anti-TG antibodies 400 
underwent a slow but constant increase from week 0 to week 24 p.i. 401 
 High levels of anti-KLH antibodies were also detected in the infected sheep (Fig. 5(E), 402 
5(F)). Anti-KLH IgG levels peaked by week 4-8 and remained high up to week 24. Anti-KLH 403 
IgM levels peaked by week 4 and decreased to a minimum by week 8-12; after that time, they 404 
increased slightly up to week 24. 405 
 Moderate to high levels of anti-LeX antibodies were present in all the infected sheep 406 
(Fig. 5(G), 5(H)). Anti-LeX IgG levels peaked between weeks 4 to 8 and then decreased but 407 
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remained detectable until week 24. Anti-LeX IgM levels peaked by week 4 and decreased 408 
slightly, although within a moderate range, until week 24. 409 
 Moderate levels of anti-LeY antibodies were also present in all the sheep analyzed (Fig. 410 
5(I), 5(J)). The anti-LeY response was very similar to the anti-TG response; i.e., the  levels of 411 
both anti-LeY antibody isotypes, IgG and IgM, increased slowly but constantly from week 0 to 412 
week 24 p.i. At the time of sacrifice, the levels of anti-LeY antibodies reached values 2- to 3-413 
fold higher than the pre-infection level. 414 
 415 
4. Discussion 416 
 417 
As pointed out in the Introduction, the aim of this work was dual: on one hand to 418 
characterise the glycans expressed by adult S. bovis worms on their excreted/secreted and 419 
tegumental glycoproteins, and -on the other- to identify the glycoproteins bearing those glycans. 420 
We chose these two protein fractions, ES and TG, because they contain the glycoproteins that 421 
are exposed to the host during infection and this affords their glycans the opportunity to 422 
participate in the host-parasite interplay. Such involvement would make these glycans -and their 423 
carrier glycoproteins- potential targets for immunodiagnostics and vaccines (Nyame et al., 2003, 424 
2004). 425 
 We started the characterization of the glycans of the ES and TG with a simple 1-D lectin 426 
blotting in which we used as many as 8 lectins that covered a broad range of binding 427 
specificities for terminal carbohydrate sequences (Fig. 1(C)). This lectin binding assay provided 428 
us with information about the type of terminal sugar sequence present -or absent- on the ES and 429 
TG glycoproteins, guiding us in later analyses. 430 
Not surprisingly, the 1-D lectin blot confirmed the absence of sialic acid residues on the 431 
ES and TG glycoproteins of S. bovis. This finding is consistent with the fact that the sialic acid 432 
is lacking in schistosome glycans in general (Nyame et al. 1998). 433 
The 1-D lectin blot indicated that the ES and TG glycoproteins also lacked the 434 
carbohydrate motifs recognized by lectins PNA (Galβ1-3GalNAc-Ser/Thr) and DSA (LacNAc, 435 
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GlcNAc-Ser/Thr). The absence of these motifs from adult S. bovis ES and TG glycoproteins, 436 
however, does not rule out their presence on proteins from other parts of adult worms or even 437 
other developmental stages of S. bovis. In fact, Galβ1-3GalNAc-Ser/Thr and GlcNAc-Ser/Thr 438 
have been found in S. mansoni on glycoproteins from homogenates of whole adult worms and 439 
schistosomula (Nyame et al., 1987, 1988); in addition, unusual O-glycans that terminate with 440 
GlcNAc or LacNAc have been described to occur on the S. mansoni cercarial glycocalyx 441 
(Huang et al., 2001). 442 
Lectin GNA did not recognize any glycoprotein on the TG extract, but it recognized two 443 
glycoproteins on the ES extract that were later identified as surface protein-fluke (SPF) and 444 
serine protease inhibitor (serpin) (Fig. 2(E) and Table 2). Since GNA indicates the presence of 445 
terminal mannose residues on “high mannose” and “complex”-type N-glycans, it is reasonable 446 
to speculate that the S. bovis SPF and serpin would carry this kind of N-glycans. Complex N-447 
glycans contain the so-called chitobiose core (Man3GlcNAc2), which is common to all 448 
eukaryotes. Recently, complex N-glycans in which the chitobiose core was partially substituted 449 
by the so-called core β2-xylose (Man3(Xyl)-R) and core α3-fucose (Fucα1-3GlcNAc) have been 450 
detected in S. mansoni excreted/secreted products of schistosomula, adults, and eggs (Faveeuw 451 
et al., 2003). Moreover, these N-glycans are very antigenic and induce strong Th2 responses 452 
(Faveeuw et al., loc. cit.). Since the S. bovis SPF and serpin glycoproteins are also strongly 453 
antigenic and very abundant in the ES extract (Pérez-Sánchez et al., 2006), it is tempting to 454 
surmise that they could carry complex N-glycans similar to those described in S. mansoni. 455 
Evidently, however, demonstration of this hypothesis would require detailed carbohydrate 456 
structural analyses. 457 
Regarding the SPF isoforms (Table 2), the broad range of MWs (47-191 kDa) exhibited 458 
by them is noteworthy. Although some degree of proteolysis cannot be ruled out, a better 459 
explanation for this phenomenon could be differences in the degree and type of glycosylation 460 
among isoforms. In fact, while all the SPF isoforms were recognized by GNA, those with the 461 
highest MW were also recognized by lectins WFA and LTA (Table 2), indicating the presence 462 
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of additional glycan decorations that, in turn, may account for the increase in the MW of those 463 
isoforms. 464 
The positive reaction with lectin WFA suggest that LDN (GalNAcβ1-4GlcNAcβ1) is 465 
expressed by S. bovis (Fig. 2(G)). LDN is an antigenic motif abundantly expressed by 466 
schistosomes, but also by humans and probably by many other mammals (Hokke and 467 
Yazdanbakhsh, 2005). In S. mansoni, LDN is expressed by cercariae, schistosomula, adults, and 468 
eggs, and it is localized on the surface of all vertebrate stages analyzed (Nyame at al., 2003). 469 
We found two WFA-binding glycoproteins -SFP and serpin (Table 2)- that were both present in 470 
the ES extract but not in the TG extract. Since these two glycoproteins have been reported to be 471 
tegument-associated proteins (Abath and Werkhauser, 1996), their presence in the ES extract 472 
could be explained by the shedding of tegument components to the incubation medium during 473 
preparation of the ES extract. 474 
Lectin LTA binds to the Fucα1-3GlcNAc glycan motif. This motif can be found 475 
forming part of several glycans that are abundantly expressed on the glycoproteins of 476 
schistosomes, such as LDN-F, F-LDN-F and LeX (Nyame et al., 2003; Robijn et al., 2005). 477 
Other glycans that also contain this motif are LeY and pseudo-LeY (Fucα1-3Galβ1-4(Fucα1-478 
3)GlcNAcβ1). LeY has never been found in schistosomes (Nyame et al., 1998) but pseudo-LeY 479 
has been found in schistosome cercarial glycolipids (Wuhrer et al., 2000; Meyer et al., 2005). 480 
Thus, given the ample range of glycans that could be bound by the lectin LTA and the 481 
fact that many of these glycans are present in schistosome glycoproteins, the high number of 482 
bands that were recognized by LTA in the adult S. bovis ES and TG extracts (Fig. 1(C)) was not 483 
unexpected. Very similar band profiles have been revealed by lectin LTA on Triton X-100 484 
extracts from whole S. haematobium and S. japonicum adult worms (Nyame et al., 1998), which 485 
suggests strong similarities among the fucosylated glycoproteins of adult S. bovis, S. 486 
haematobium and S. japonicum worms. 487 
Regarding the identification of the LTA-binding fucosylated glycoproteins of adult S. 488 
bovis worms, the analysis by mass spectrometry of a fraction of the LTA-binding spots allowed 489 
us to identify 7 glycoproteins: SPF, ATPGK, enolase, FbisPA, GAPDH, CBendo and actin. All 490 
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of them except SPF, CBendo and actin were present in both extracts. This is consistent with the 491 
findings of previous works (Pérez-Sanchez et al., 2006), except for GAPDH and FbisPA, which 492 
were only found in the TG extract. 493 
Moreover, not all these LTA-binding glycoproteins were antigenic. Only the high-MW 494 
SPF isoforms, enolase, GAPDH and CBendo were antigenic (Perez-Sánchez et al., loc. cit.), 495 
suggesting that there is no direct relationship between the presence of the Fucα1-3GlcNAc motif 496 
in S. bovis glycoproteins and the antigenicity of these glycoproteins. In fact, the glycans that 497 
contain only this kind of fucosylated motif, such as LDN-F and LeX, generally induce weak 498 
antibody responses, although they may have immunomodulatory effects (Robijn et al., 2005). 499 
By contrast, glycans containing the Fucα1-3GalNAcβ1- or Fucα1-2Fucα1- motifs, such as F-500 
LDN(-F) and (DF-)LDN-DF, induce strong antibody responses in human and primate 501 
schistosomiasis (van Remoortere et al., 2003; Robijn et al., 2005; Wuhrer et al., 2006b). Bearing 502 
this in mind, we analysed whether the ES and TG glycoproteins of adult S. bovis worms carried 503 
F-LDN(-F) and LeX. Additionally, since LeY also contains the LTA-binding motif Fucα1-504 
3GlcNAc we also checked the presence of LeY in those glycoproteins. 505 
It is well established that KLH and schistosomes share the carbohydrate epitopes F-506 
LDN(-F) (Geyer et al., 2005); this is indeed why we used an anti-KLH polyclonal antibody as a 507 
probe in the search for F-LDN(-F)-containing glycans in S. bovis. The 1-D western blots with 508 
anti-KLH clearly showed that the F-LDN(-F) epitopes were absent from the adult ES and TG 509 
glycoproteins (Fig. 1 (B)). This antibody, however, recognized numerous bands on extracts of 510 
glycoproteins from the cercariae and eggs of S. bovis (personal observation, data not shown). 511 
These results suggest that S. bovis expresses F-LDN(-F) on cercarial and egg glycoproteins but 512 
not on adult worm glycoproteins, in agreement with the results described for S. mansoni by 513 
Robijn et al. (2005). These authors also reported that S. mansoni expresses F-LDN(-F) on 514 
glycolipids of cercariae, adults and eggs. Accordingly, it is possible that S. bovis might also 515 
express F-LDN(-F) on its glycolipids, although here this point was not assessed. In any case, the 516 
fact that S. bovis expresses F-LDN(-F), at least in its cercarial and egg glycoproteins, is also 517 
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supported by the strong IgG and IgM antibody responses against KLH that we observed in all 518 
the sheep infected with S. bovis (Fig. 5(E), 5(F)). 519 
In the search for LeX- and LeY-bearing glycoproteins within the adult worm ES and TG 520 
extracts we obtained some remarkable results (Fig. 4(B), 4(C) and Table 4). First, we found LeX 521 
in S. bovis, as was expected in view of its abundant expression in the Schistosoma genus 522 
(Nyame et al., 1998; Hooke and Yazdanbakshs, 2005). However, we also found LeY and this 523 
observation was somewhat surprising because this glycan has never been recorded in the genus 524 
Schistosoma. In this sense, Nyame et al. (1998) elegantly demonstrated the absence of LeY, Leb 525 
(Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1) and Lea (Galβ1-3(Fucα1-4)GlcNAcβ1) in the 526 
Schistosoma species that infect humans. 527 
 Second, we found both the LeX and LeY antigens in the TG but not in the ES extract. 528 
This is in agreement with the observation that LeX is expressed by other schistosomes on their 529 
tegument surface (Nyame et al., 2003). Nevertheless, we found both Lewis antigens in two 530 
glycoproteins, ATPGK and GAPDH, that were present in both the ES and TG extracts, 531 
suggesting that the ATPGK and GAPDH isoforms present in the ES extract do not express 532 
Lewis groups. 533 
Third, in the TG extract the two anti-Lewis monoclonal antibodies recognised exactly 534 
the same isoforms of ATPGK and GAPDH. This finding, together with the well established 535 
absence of LeY in the human-infecting schistosomes, suggested that we might be facing a 536 
problem of cross-reactivity between both monoclonal antibodies, such that the anti-LeY 537 
antibody would be recognising the LeX antigen. However, we ruled out this possibility because 538 
both antigens (LeX and LeY) are quite different and, above all, because we observed by means of 539 
an inhibition ELISA -using the neoglycoproteins BSA-LNFPIII and BSA-LeY- that there was no 540 
cross-reactivity at all between both monoclonal antibodies (data not shown). Consequently, the 541 
presence of LeY on these two S. bovis glycoproteins appeared to be real. In addition, we 542 
observed antibody responses against both the LeX and LeY epitopes in all the sheep infected 543 
with S. bovis (Fig. 5(G)-5(J)). The existence of these humoral responses and the different 544 
kinetics of the anti-LeX and anti-LeY antibodies reinforced the idea that S. bovis actually 545 
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expresses these two different Lewis antigens. Finally, the spot pattern recognized by lectin 546 
UEA-I on the TG extract also supported this idea. As can be seen in Fig. 3 (F), the ATPGK and 547 
GAPDH isoforms that were recognized by the anti-LeY monoclonal antibody were also bound 548 
by lectin UEA-I, which confirms that they carry the Fucα1-2Galβ1- motif, which, in turn, forms 549 
part of the LeY antigen. 550 
Overall, these results indicate that both the LeX and LeY antigens are co-expressed on 551 
the same isoforms of ATPGK and GAPDH by adult S. bovis worms, although definitive 552 
demonstration of this point requires detailed structural analyses. 553 
Regarding the possible biological significance of this fact, some data recently published 554 
in relation to the Lewis antigens could provide some clues. It has been demonstrated that the 555 
Lewis antigens LeX, Lea, Leb and LeY bind to the host lectin DC-SIGN  through the amino acid 556 
Val351 (see Meyer et al., 2005). It has also been shown that DC-SIGN also binds to pseudo-LeY, 557 
a glycan antigen that so far only has been found within schistosomes, in particular on cercarial 558 
glycolipids from S. mansoni (see Meyer et al., 2005). DC-SIGN is a C-type lectin expressed on 559 
the surface of dendritic cells, which in a concerted action with Toll-like receptors determine the 560 
balance in dendritic cells between the induction of immunity and tolerance against a particular 561 
antigen. It has been hypothesized that the binding of parasite LeX and pseudo-LeY to host DC-562 
SIGN may allow schistosomes to mislead the host immune system by down-regulating dendritic 563 
cell function in all stages of infection (Meyer et al., loc. cit). Perhaps this hypothesis could also 564 
be applied to the LeX and LeY expressed by S. bovis. 565 
In conclusion, the identification in S. bovis of all these glycans and carrier proteins 566 
provides new and exciting perspectives for future studies on the biological roles of these 567 
molecules in host-S. bovis relationships, and, perhaps, for their potential use as diagnostic or 568 
vaccine antigens. 569 
 570 
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 695 
Table 1. Lectins used as probes in the screening of the ES and TG extracts. 696 
 697 
Lectin Source Carbohydrate motif binding specificity Label 
Working 
concentration 
GNA Galantus nivalis 
Manα1-3Man 
Manα1-6Man 
Manα1-2Man 
 
digoxigenin 1 µg/ml 
SNA Sambucus nigra  NeuNAcα2-6Galβ   digoxigenin 1 µg/ml 
MAA Maack ia amurensis NeuNAcα2-3Galβ  
 
digoxigenin 5 µg/ml 
DSA Datura stramonium 
Galβ1-4GlcNAc (LacNAc) 
GlcNAc-Ser/Thr 
 
digoxigenin 1 µg/ml 
PNA Arachis hypogea  Galβ1-3GalNAc-Ser/Thr  digoxigenin 10 µg/ml 
WFA Wisteria floribunda GalNAcβ1-4GlcNAc (LDN) 
 
biotin 1 µg/ml 
LTA Lotus tetragonolobus Fucα1-3GlcNAc  biotin 1 µg/ml 
UEA.I Ulex europaeus Fucα1-2Galβ   biotin 1 µg/ml 
 698 
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Table 2. Identification by MALDI-TOF-TOF MS and NCBInr database searching of the ES 699 
proteins revealed by lectins LTA, GNA and WFA (from Fig. 2). SPF, surface protein-fluke; 700 
Pre-proSA, pre-pro serum albumin; ATPGK, ATP:guanidino kinase; Serpin, serine protease 701 
inhibitor; FbisPA, fructose 1,6 bisphosphate aldolase; GAPDH, glyceraldehyde-3-phosphate 702 
dehydrogenase; CBendo, cathepsin B endopeptidase. 703 
 704 
Spot 
no. Lectin bound Protein Species 
Accession No. 
(NCBI) 
MW 
(kDa) 
Theo/exp 
pI 
Theo/exp 
Cover. 
% 
MASCOT 
score 
1 LTA,GNA,WFA SPF S. mansoni T30271 191/191 4.7/5.1 6 94 
2 LTA,GNA,WFA SPF S. mansoni T30271 191/153 4.7/5.2 5 84 
3 LTA,GNA,WFA SPF S. mansoni T30271 191/123 4.7/5.1 6 90 
32 GNA SPF S. mansoni T30271 191/51 4.7/5.5 7 101 
33 GNA SPF S. mansoni T30271 191/52 4.7/5.6 6 83 
34 GNA SPF S. mansoni T30271 191/52 4.7/5.7 5 83 
47 GNA SPF S. mansoni T30271 191/46 4.7/5.4 6 86 
48 GNA SPF S. mansoni T30271 191/46 4.7/5.5 6 90 
49 GNA SPF S. mansoni T30271 191/47 4.7/5.6 7 101 
16 LTA Pre-proSA Ovis aries NP_001009376 71/89 5.8/6.0 19 120 
17 LTA Pre-proSA Ovis aries NP_001009376 71/89 5.8/6.1 13 84 
18 LTA Pre-proSA Ovis aries NP_001009376 71/89 5.8/6.2 14 96 
19 LTA Pre-proSA Ovis aries NP_001009376 71/88 5.8/6.62 16 105 
20 LTA Pre-proSA Ovis aries NP_001009376 71/88 5.8/6.3 19 120 
25 LTA ATPGK S. mansoni P16641 77/93 8.1/7.3 19 120 
26 LTA ATPGK S. mansoni P16641 77/93 8.1/7.4 34 208 
27 LTA ATPGK S. mansoni P16641 77/92 8.1/7.6 12 112 
28 LTA ATPGK S. mansoni P16641 77/92 8.1/7.8 19 120 
29 GNA,WFA serpin b S. haematobium AAA19730 44/66 4.9/5.4 - 47 
30 GNA,WFA serpin b S. haematobium AAA19730 44/65 4.9/5.5 - 49 
31 GNA,WFA serpin a S. haematobium AAA19730 44/66 4.9/5.6 19 88 
35 LTA Enolase a S. mansoni AAC46886 47/57 6.2/6.9 10 111 
36 LTA Enolase S. mansoni AAC46886 47/57 6.2/7.1 17 113 
38 LTA FbisPA S. mansoni AAA57567 40/46 7.4/6.8 49 225 
39 LTA FbisPA S. mansoni AAA57567 40/46 7.4/7.0 17 99 
40 LTA FbisPA S. mansoni AAA57567 40/46 7.4/7.1 49 225 
41 LTA FbisPA S. mansoni AAA57567 40/46 7.4/7.4 51 228 
42 LTA FbisPA S. mansoni AAA57567 40/46 7.4/7.7 51 230 
43 LTA GAPDH  S. mansoni JL0121 37/44 7.7/7.8 21 90 
44 LTA GAPDH a S. mansoni JL0121 37/44 7.7/8.4 21 115 
45 LTA GAPDH S. mansoni JL0121 37/44 7.7/8.5 17 81 
46 LTA GAPDH a S. mansoni JL0121 37/44 7.7/8.6 17 134 
51 LTA CBendo  S. mansoni CAC85211 40/41 5.7/6.2 21 88 
52 LTA CBendo S. mansoni CAC85211 40/41 5.7/6.4 19 86 
 705 
a Spots identified using PMF data in combination with MS/MS data. 706 
b Spots unidentified using PMF data but identified using MS/MS data. 707 
 708 
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 709 
Table 3. Identification by MALDI-TOF-TOF MS and NCBInr database searching of the TG 710 
proteins revealed by the lectins LTA and UEA-I (from Fig. 3). ATPGK, ATP:guanidino kinase; 711 
FbisPA, fructose 1,6 bisphosphate aldolase; GAPDH, glyceraldehyde-3-phosphate 712 
dehydrogenase. 713 
 714 
Spot 
no. Lectin bound Protein Species 
Accession No. 
(NCBI) 
MW (kDa) 
Theo/exp 
pI 
Theo/exp 
Cover. 
% 
MASCOT 
score 
2 LTA, UEA-I ATPGK S. mansoni P16641 77/90 8.1/7.7 19 120 
3 LTA, UEA-I ATPGK S. mansoni P16641 77/90 8.1/7.8 34 208 
4 LTA, UEA-I ATPGK S. mansoni P16641 77/89 8.1/8.0 12 112 
22 LTA, UEA-I Enolasea S. mansoni AAC46886 47/58 6.2/6.7 22 90 
23 LTA, UEA-I Enolasea S. mansoni AAC46886 47/58 6.2/6.7 10 111 
24 LTA, UEA-I Enolase S. mansoni AAC46886 47/58 6.2/6.8 14 97 
25 LTA, UEA-I Enolase S. mansoni AAC46886 47/58 6.2/7.0 16 86 
26 LTA, UEA-I Enolase  S. japonicum P33676 48/58 6.2/7.2 24 125 
29 LTA, UEA-I Enolase b S. mansoni AAC46886 47/48 6.2/6.6 - 61 
30 LTA, UEA-I Enolase b S. mansoni AAC46886 47/48 6.2/6.8 - 82 
27 LTA Actin  S. mansoni AAA62377 42/48 5.5/6.2 29 152 
28 LTA Actin S. mansoni AAA62377 42/46 5.5/6.4 18 113 
33 LTA, UEA-I FbisPA S. mansoni AAA57567 40/48 7.4/7.4 51 228 
35 LTA, UEA-I FbisPA S. mansoni AAA57567 40/48 7.4/7.6 17 99 
36 LTA, UEA-I FbisPA S. mansoni AAA57567 40/48 7.4/7.7 51 230 
31 LTA, UEA-I GAPDH b S. mansoni JL0121 37/42 7.7/7.1 - 107 
32 LTA, UEA-I GAPDH S. mansoni JL0121 37/44 7.7/7.2 22 119 
34 LTA, UEA-I GAPDH  S. mansoni JL0121 37/44 7.7/7.6 17 81 
37 LTA, UEA-I GAPDH  S. mansoni JL0121 37/44 7.7/7.8 21 90 
38 LTA, UEA-I GAPDHa S. mansoni JL0121 37/44 7.7/8.4 21 115 
 715 
a Spots identified using PMF data in combination with MS/MS data. 716 
b Spots unidentified using PMF data but identified using MS/MS data. 717 
 718 
 719 
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Table 4. Identification by MALDI-TOF-TOF MS and NCBInr database searching of the TG 720 
proteins that contain LeX and LeY groups (from Fig. 4). ATPGK, ATP:guanidino kinase; 721 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.  722 
 723 
Spot 
no. 
Protein Species Accession No. 
(NCBI) 
MW (kDa) 
Theo/exp 
pI 
Theo/exp 
Cover. 
% 
MASCOT 
score 
1, 9 ATPGK S. mansoni P16641 77/90 8.1/7.7 19, 21 120, 123 
2, 10 ATPGK S. mansoni P16641 77/99 8.1/7.8 30, 34 201, 208 
3, 11 ATPGK S. mansoni P16641 77/89 8.1/8.0 12,16 112, 118 
4, 12 GAPDH S. mansoni JL0121 37/44 7.7/7.6 22, 27 100, 115 
5, 13 GAPDH S. mansoni JL0121 37/44 7.7/7.9 21, 26 90, 115 
6, 14 GAPDH S. mansoni JL0121 37/44 7.7/8.3 23, 25 115, 115 
7, 15 GAPDH S. mansoni JL0121 37/44 7.7/8.4 15, 17 78, 81 
8, 16 GAPDH S. mansoni JL0121 37/44 7.7/8.5 28, 29 134, 139 
 724 
 725 
 726 
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 727 
Figure captions 728 
 729 
Figure 1. (A) SDS-PAGE: the ES and TG extracts were resolved in 5-20% polyacrylamide gels 730 
and stained with silver nitrate. (B) 1-D Western blots of the ES and TG immunostained with the 731 
polyclonal anti-KLH antibody (developed with 4-Cl-1-naphthol) or the anti-LeX and anti-LeY 732 
monoclonal antibodies (developed with luminol). (C) 1-D lectin blots of the ES and TG 733 
extracts: lectins GNA, SNA, MAA, DSA, PNA, WFA, LTA and UEA-I were used as probes. 734 
The arrow indicates the band not abolished in the inhibitory assays. 735 
 736 
Figure 2. Two-dimensional images of the ES extract. (A) and (B) silver-stained 12% 737 
polyacrylamide gels with pH ranges of 5-8 and 7-10. Two-dimensional lectin blots in the pH 5-738 
8 and 7-10 ranges with LTA (C) and (D), GNA (E) and (F) and WFA (G) and (H). Numbered 739 
circles indicate the lectin-binding spots, which were analyzed by mass spectrometry. 740 
 741 
Figure 3. Two-dimensional images of the TG extract. (A) and (B) silver-stained 12% 742 
polyacrylamide gels with pH ranges of 5-8 and 7-10. Two-dimensional lectin blots in the pH 5-743 
8 and 7-10 ranges with LTA (C) and (D), and UEA-I (E) and (F). Numbered circles indicate the 744 
LTA- and UEA-I-binding spots, which were analyzed by mass spectrometry. 745 
 746 
Figure 4. Immunoprecipitation and identification of the LeX- and LeY-bearing glycoproteins 747 
from the TG. (A) Silver-stained SDS-PAGE of the supernatants (1) and pellets (2) of the 748 
coupling reaction of the anti-LeX and anti-LeY mAb, and TG to protein G-Sepharose 4B. HC, 749 
mAb heavy chains; LC, mAb light chains. Arrows indicate contaminants also bound by protein 750 
G. (B) Silver-stained SDS-PAGE of the supernatants (1) and pellets (2) from the 751 
immunoprecipitation of TG with the mAb coupled to protein G-Sepharose 4B. The 752 
inmunocaptured bands are circled and annotated with their apparent MW. (C) Images of the 753 
immunoprecipitation pellets after 2-D electrophoresis in gels of 12% polyacrylamide and pH 754 
 32 
ranges of 5-8 and 7-10. Numbered circles indicate the spots corresponding to the 755 
immunocaptured proteins, which were analyzed by mass spectrometry 756 
 757 
Figure 5. ELISA. IgG and IgM antibody responses to ES, TG, KLH and the neoglycoproteins 758 
BSA-LNFPIII (LeX) and BSA-LeY in three sheep infected with S. bovis. Each series of points 759 
represents an individual sheep. The plots are typical of three experiments. 760 
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